WA PMP Access by Public Payers. PDMP North Regional Meeting St. Louis, MO April 23-24
|
|
- Lawrence Nash
- 6 years ago
- Views:
Transcription
1 WA PMP Access by Public Payers PDMP North Regional Meeting St. Louis, MO April 23-24
2 Public Insurer Access PDMP Statute: Allows PDMP data to be provided to Medicaid and Workers Compensation Primary Goal: To provide for better patient care and promote patient safety. Secondary Goal: To assist our public insurers in preventing fraud and saving state funding.
3 Two Types of Access 1. Healthcare Practitioners within the Health Care Authority (HCA - Medicaid) and Department of Labor and Industries (LNI Workers Compensation) can login with individual account access and request a patient history report. 2. Once a month each agency provides a file through secure file transfer of all their clients/patients (names, DOB). Our vendor then provides matching data for each client/patient in a file that is returned through secure file transfer.
4 LNI - PDMP Bulk Transfer PDMP bulk transfer uses: Identifying pre-existing opioid use Identifying duplicative prescriptions (in process) Identifying prescribing outliers (future) Bulk transfer available in May 2012
5 LNI Early Opioid Intervention Pilot Identify claims that are days old AND received 1 opioid prescriptions within 60 days before the injury Clinical review and intervention by a nurse or pharmacist as necessary Better coordination of medical care and management of claims, promote use of PMP and reduce cost and disability
6 LNI - Early Opioid Intervention Pilot new claims meet this criteria each month (3-4% of all claims allowed) Prioritization Criteria Chronic opioid use ( 3 prescriptions in previous 3 months) High dose opioid (> 120mg/d MED) Other controlled substances (e.g. benzodiazepines, sedativehypnotics Timeloss (wage replacement) Clinical review is prioritized by the number of criteria met
7 Future LNI Initiatives Complete the Early Opioid Intervention Pilot Require L&I s providers to access PDMP before prescribing opioids for a work-related injury (new guideline) Identify duplicative prescriptions and create a process to intervene Identify prescribing outliers to improve L&I s new provider network
8 HCA Patient Review & Coordination (PRC) Aimed at over-utilizing clients Decrease and control over-utilization and inappropriate use of health care services Minimize medically unnecessary services and addictive drug use Client and provider education and coordination of care Assist providers in managing PRC clients by providing available resource information to facilitate coordination of care Reduce overall expenditures
9 PDMP Assistance to PRC to Date As of May 2012 the PDMP has assisted in identifying 20 clients for the PRC program to date (through 5 months of using just the individual query site) The minimum time that a client is in PRC is 2 years and they can be 3 years or 5 years. These 20 clients represent 67 PRC client lock-in years at $6,000 per year. This amounts to over $400,000 in savings. 9
10 PDMP Bulk Data use by PRC PRC Program compliance analysis Of 3,800 PRC clients 1,900 are currently Fee For Service Of these 1,900, 1,170 clients have at least 1 PMP prescription. Of the 1,170 clients filling prescriptions 489 Clients paid cash for 2,470 prescriptions. And 243 additional clients are listed as paid by 04 private insurance with an additional 2,059 prescriptions. This would be a total of 732 clients filling 4,529 total prescriptions By contrast 898 clients filled 12,240 prescriptions paid for by Medicaid during this same period. 10
11 PDMP Bulk Data use by PRC Client Identification analysis Allows improved algorithms with clients. Identified >2000 Clients in 2012 with Cash and Medicaid paid schedule prescriptions on the same day. Identified 478 clients where cash and Medicaid fills were < 10 days apart, the scripts were overlapping, for the same drug and from different prescribers. Currently reviewing the top utilizers of the 478 for PRC placement. 11
12 HCA - Narcotic Review Program The Narcotic Review Program (NRP) evaluates Medicaid clients who are receiving high doses of opioid narcotics to verify the medical need for these exceptional doses. It only applies to client with chronic non-cancer pain. Each narcotic prescription for these clients requires authorization as long as the client is in the narcotic review program. A client s narcotic use will be adjusted to minimize pain and maximize function. The lowest effective dose, or zero use is determined by medical necessity and clinical considerations. PDMP Data found that 83% of clients in the NRP had scripts that were not paid for by Medicaid. 12
13 Future HCA Initiatives HCA will be using bulk data to augment our lock-in PRC program. HCA has already been working on threshold reports to go to managed care plans concerning clients using cash. HCA will be sending threshold reports to: Prescribers with clients prescription Information Pharmacies who accept cash from Medicaid clients in violation of their core provider agreement 13
14 Refining the Bulk Transfer Key Areas that were fine tuned: Data Fields: NPI, Payment Type, etc Handling reversals, voids, duplicates Provide back in return file LNI patient name for matching Key Areas for improvement: Payment Type entered more accurately NPI # - require is to be reported Patient ID more reliable matching
15 Program Contact Chris Baumgartner, PMP Director Washington State Dept. of Health Phone: Website:
16
Managed Care Pushes for Safer Opioid Oversight
Page 1 of 6 Clinical AUGUST 11, 2017 Managed Care Pushes for Safer Opioid Oversight High-risk pain Rx eyed Denver Health systems haven t escaped the nation s ongoing opioid crisis, as evidenced by surging
More informationChallenges for U.S. Attorneys Offices (USAO) in Opioid Cases
Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases Overview On August 2, 2017, U.S. Attorney General Jeff Sessions announced a pilot program whereby a new federal data analysis program is being
More informationThe Wisconsin Prescription Drug Monitoring Program
The Wisconsin Prescription Drug Monitoring Program DHS 2018 WI Opioid Forum April 12, 2018 Learning Objectives 1. How the WI epdmp supports healthcare professionals in making informed prescribing, dispensing
More informationThe Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin.
The Wisconsin Prescription Drug Monitoring Program Wisconsin Nurses Association Jail Health Care Conference May 21, 2018 WI PDMP Timeline PDMP Overview January 2013 WI PDMP operational April 2017 WI epdmp
More informationMandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Arizona Amends worker s compensation statute to require physicians to request PMP information within two (2) business days of writing or dispensing prescriptions for at least a 30 day supply of an opioid
More informationMandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Arizona Amends worker s compensation statute to require physicians to request PMP information within two (2) business days of writing or dispensing prescriptions for at least a 30 day supply of an opioid
More informationMandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Alaska Requires adoption of regulations that provide that a practitioner query the PDMP prior to dispensing, prescribing, or administering a Sch. II or III controlled substance; query is not required for
More informationPatient Review and Coordination Program
Patient Review and Coordination Program For Medical Assistance Clients Who Need Assistance In Appropriate Use of Phyllis Coolen, RN, MN Division of Healthcare Health and Recovery Administration January
More informationThe Changing Landscape of Opioids & Workers Compensation. Presented by: David Campbell, MA, CRC State of Michigan Workers Compensation Agency
The Changing Landscape of Opioids & Workers Compensation Presented by: David Campbell, MA, CRC State of Michigan Workers Compensation Agency 1 The Changing Landscape of Opioids & Workers Compensation is
More informationApril 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)
New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Nurse Practitioner Council New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) Peter Ryba, PharmD PMP Director
More informationState, District, or Territory Criteria for Mandatory Enrol ment or Query of PDMP
State, District, or Territory Alabama Arizona Arkansas Criteria for Mandatory Enrollment or Query of PDMP Before renewing an Alabama Controlled Substances Certificate, the applicant shall have a current
More informationWashington State PMP Data Mapping Project
Washington State PMP Data Mapping Project 2014 Category 3 Grant Harold Rogers Category 3 Grantee Meeting February 25, 2015 Washington State BACKGROUND: OPIOID ISSUES AND PLANNING 2 WA Unintentional Opioid
More informationPATIENT SIGNATURE: DOB: Date:
CINCINNATI PAIN PHYSICIANS, LLC (CPP) ACKNOWLEDGEMENT OF RECEIPT OF NOTICE OF PRIVACY PRACTICES By signing below, I acknowledge that I have received a copy of CPP s Notice of Privacy Practices. The Notice
More informationCurbing Prescription Drug Abuse in Medicaid
Curbing Prescription Drug Abuse in Medicaid Joint Legislative Health Care Oversight Committee October 12, 2010 Dr. Lisa Weeks, BSPharm, PharmD Pharmacy and Ancillary Services Division of Medical Assistance
More informationWILLIAMS, WYCKOFF & OSTRANDER, PLLC Attorneys at Law
WILLIAMS, WYCKOFF & OSTRANDER, PLLC Attorneys at Law Wayne L. Williams Douglas P. Wyckoff Dane D. Ostrander 2958 Limited Lane N.W. P O Box 316 Olympia, WA 98507 Telephone (360) 528-4800 Telefax (360) 943-2430
More informationMedicare Advantage Outreach and Education Bulletin
Medicare Advantage Outreach and Education Bulletin Blue Cross and Blue Shield of Georgia Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain
More informationPrescription Monitoring Program (PMP)
06/15/2018 FACT SHEET Implementation of Enacted Prescribing Limits and Requirements and Relevant Opioid Prescribing Laws and Rules Background: The 2016 law (Chapter 488) makes five major changes to opioid
More information2017 PGIP Fact Sheet Electronic Prescribing of Controlled Substances (EPCS)
2017 PGIP Fact Sheet Electronic Prescribing of Controlled Substances (EPCS) Overview Value Partnerships, in conjunction with the Blue Cross Pharmacy team, has created the Electronic Prescribing of Controlled
More informationDental Dialog. Highlighting news, programs, policies and tips for Aetna participating dentists. Fall aetna.com
Dental Dialog Fall 2017 Highlighting news, programs, policies and tips for Aetna participating dentists 43.22.802.1-FA A (10/17) aetna.com Dental Dialog Fall 2017 Inside this issue The opioid epidemic...
More informationPrescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP) District of Columbia Information contained in this presentation is accurate as of September 2017 Meet the Speaker Tadessa Harper-Nichols Program Specialist Pharmaceutical
More informationPrescription Medication Guidelines for Medical Providers in CorVel s CorCare and Care IQ Networks
Prescription Medication Guidelines for Medical Providers in CorVel s CorCare and Care IQ Networks Patient Health and Safety Guidelines Prescription Medications Policy Update / April 2017 In connection
More informationNM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2018 (2018Q3)
NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 218 () Substance Abuse Epidemiology Section Prescription Drug Overdose Prevention Program Injury and Behavioral Epidemiology Bureau
More informationIdaho DUR Board Meeting Minutes
Date: July 16, 2015 Time: 9am-1:30pm Idaho DUR Board Meeting Minutes Location: Idaho Medicaid, 3232 Elder Street, Boise, Idaho, Conference Room D-West Moderator: Mark Turner, M.D. Committee Member Present:
More informationSubmitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis
STATEMENT FOR THE RECORD Submitted to the House Energy and Commerce Committee Federal Efforts to Combat the Opioid Crisis October 25, 2017 America s Health Insurance Plans 601 Pennsylvania Avenue, NW Suite
More informationSTATE OF NEW JERSEY OFFICE OF THE STATE COMPTROLLER MEDICAID FRAUD DIVISION
STATE OF NEW JERSEY OFFICE OF THE STATE COMPTROLLER MEDICAID FRAUD DIVISION COMPLIANCE AUDIT REVIEW OF SUBOXONE FINAL AUDIT REPORT A. Matthew Boxer September 25, 2013 COMPTROLLER Executive Summary As part
More informationE-Prescribing, EPCS & PDMP: An Update
E-Prescribing, EPCS & PDMP: An Update Melissa A. Kotrys, MPH Chief Executive Officer July 27, 2018 Arizona Health-e Connection is now Health Current Arizona s primary resource for health information technology
More informationSTATE PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS): A NATIONAL PERSPECTIVE
STATE PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS): A NATIONAL PERSPECTIVE PRESENTATION ON BEHALF OF THE NATIONAL ASSOCIATION OF STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) BY SHERRY L. GREEN OVERVIEW
More informationMedication trends shaping workers compensation. A 2018 update of the prevailing industry influences impacting pharmacy outcomes
Medication trends shaping workers compensation A 2018 update of the prevailing industry influences impacting pharmacy outcomes This page intentionally left blank Trends impacting workers compensation pharmacy
More informationUpdated: 08/2017 DMMA Approved: 11/2017
Request for Prior Authorization for Therapy to Treat Binge Eating Disorder Website Form www.highmarkhealthoptions.com Submit request via: Fax - 1-855-476-4158 All requests for medications to treat Binge
More informationNew Mexico Board of Pharmacy Prescription Monitoring Program (PMP)
New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) PDMP West Regional Meeting PMP Collaboration with the NM Department of Health April 26, 2018 New Mexico Board of Pharmacy Prescription
More informationImmunization Conference
Immunization Conference Wyoming Medicaid Covered Services & Billing Requirements May 11 & 12, 2016 Presenter s: Melissa Davis & Elisa Mauch, Field Representative s What is Medicaid? Medicaid helps pay
More informationNYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement.
NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement May 2, 2018 1 May 2, 2018 2 Bureau Overview May 2, 2018 3 HISTORY 1850--Bureau
More informationPDMP Track: Linking and Mapping PDMP Data. Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health
PDMP Track: Linking and Mapping PDMP Data Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health Disclosure Statement Gillian Leichtling and Chris Baumgartner have disclosed no
More informationRisk Classification Modeling to Combat Opioid Abuse
Risk Classification Modeling to Combat Opioid Abuse Improve Data Sharing to Identify High-Risk Prescribers of Opioids Christopher Sterling Chief Statistician NCI, Inc. www.nciinc.com 11730 Plaza America
More information3. Has the patient had a sustained improvement in Pain or Function (e.g. PEG scale with a 30 percent response from baseline)?
Pharmacy Prior Authorization AETA BETTER HEALTH KETUCK Opioids Long-Acting and Short-Acting (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review
More information4/26/2018. Bureau of Professional Licensing. MAPS Updates & Opportunities. MAPS Background. Registration. MAPS Update
Bureau of Professional Licensing MAPS Updates & Opportunities April 28, 2018 Presented by Andrew Hudson, Manager Haley Winans, Analyst Drug Monitoring Section Bureau of Professional Licensing BPL-MAPS@Michigan.gov
More informationIdaho DUR Board Meeting Minutes
Idaho DUR Board Meeting Minutes Date: January 21, 2016 Time: 9am-1:30pm Location: Idaho Medicaid, 3232 Elder Street, Boise, Idaho, Conference Room D-West Moderator: Mark Turner, M.D. Committee Members
More informationMedicare Advantage Outreach and Education Bulletin
Medicare Advantage Outreach and Education Bulletin Anthem Blue Cross and Blue Shield Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain management.
More informationSeptember 22, National Association of Attorneys General 1850 M Street, NW, 12 th Floor Washington, DC Prescription Opioid Epidemic
National Association of Attorneys General 1850 M Street, NW, 12 th Floor Washington, DC 20036 RE: Prescription Opioid Epidemic On behalf of America s Health Insurance Plans (AHIP), thank you for your leadership
More informationLouisiana. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Louisiana Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationLaw Enforcement and the Prescriber Enforcement Action Protocol
Law Enforcement and the Prescriber Enforcement Action Protocol Ken Clark U.S. Department of Justice United States Attorney s Office District of Maryland Opioid Abuse Approx 2.6 fatal overdoses per day
More informationThe Role of the PDMP: Foundational Knowledge and Best Practices
The Role of the PDMP: Foundational Knowledge and Best Practices Brent I. Fox, PharmD, PhD Health Outcomes Research and Policy Harrison School of Pharmacy Auburn University DISCLOSURE I, Brent Fox, have
More informationIllinois Prescription Monitoring Program. Sarah Pointer, Pharm D. Clinical Director of the Illinois Prescription Monitoring Program
Illinois Prescription Monitoring Program Sarah Pointer, Pharm D. Clinical Director of the Illinois Prescription Monitoring Program Agenda Provide an overview of the Illinois Prescription Monitoring Program
More information4/24/15. New Mexico s Prescription Monitoring Program. Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy. New Mexico and the PMP
New Mexico s Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy New Mexico and the PMP In 2012, New Mexico had the 3 nd Highest Overdose Death Rate in Nation.! 492 Deaths or a rate of 23.6
More informationAlberta WCB Policies & Information
1. What are the objectives of WCB regarding the authorization of prescribed opioid analgesics As part of an overall approach to effective, appropriate claims management, including the provision of and
More informationPrescription Monitoring Program. One Agency s Experience. Ron Jackson, MSW, LICSW Evergreen Treatment Services Seattle, WA
Prescription Monitoring Program One Agency s Experience Ron Jackson, MSW, LICSW Evergreen Treatment Services Seattle, WA Agency Description Private non-profit, founded 1973 $8.5 M annual budget; staff
More informationState, District, or Territory Criteria for Mandatory Query of PDMP
State, District, or Territory Alabama Alaska Arizona Criteria for Mandatory Query of PDMP Requirements for use of the PMP, including the following: 1) when prescribing a patient a controlled substance
More informationClinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)
Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT) For Apple Health clients served Fee-for-Service and through contracted Medicaid Managed Care Organizations Updated January
More informationNebraska: What s Going On with the PDMP and HIE
Nebraska: What s Going On with the PDMP and HIE Kevin C. Borcher, PharmD PDMP Program Director NeHII, Inc. BJA PDMP North Regional Meeting October 16, 2018 Nebraska PDMP Legislative Summary LB 237 (2011)
More informationMandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Alabama Requirements for use of the PMP, including the following: 1) when prescribing a patient a controlled substance of more than 30 MME per day, physicians shall query the PMP for that patient at least
More informationOklahoma. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Oklahoma Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More information2. Is this request for a preferred medication? Y N
Pharmacy Prior Authorization AETA BETTER HEALTH EW JERSE (MEDICAID) Opioids Long-Acting and Short-Acting (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review
More informationPrescription Monitoring Program Center for Excellence, Brandeis University. April 10-12, 2012 Walt Disney World Swan Resort
Prescription Monitoring Program Center for Excellence, Brandeis University April 10-12, 2012 Walt Disney World Swan Resort Accepted Learning Objectives: 1. Explain the current capabilities and contributions
More informationNotice from the Executive Officer: Promoting Compliance with the Existing Limited Use Criteria for Fentanyl Transdermal Patch
Notice from the Executive Officer: Promoting Compliance with the Existing Limited Use Criteria for Fentanyl Transdermal Patch Frequently Asked Questions 1. What is the new Health Network System feature
More informationShining a Light on MEDs Understanding morphine equivalent dose
Shining a Light on MEDs Understanding morphine equivalent dose In the workers compensation industry, 60.2 percent of claimants utilize opioid analgesics for the treatment of pain caused by a workplace
More informationBusiness Impact Analysis
ACTION: Final DATE: 05/23/2018 8:24 AM Business Impact Analysis Agency Name: Ohio Department of Medicaid (ODM) Regulation/Package Title: Dental services Rule Number(s): Rule 5160-5-01 with appendices A
More informationNorth Dakota Board of Pharmacy
North Dakota Board of Pharmacy Updates on Drug Abuse Trends, the PDMP and Medical Marijuana Mark J. Hardy, Pharm D Executive Director Disclosure Statement I have no conflict of interests to report Objectives
More informationBUPRENORPHINE/NALOXONE THERAPY DOM CLINICAL GUIDELINES AND RECOMMENDED CHANGES
BUPRENORPHINE/NALOXONE THERAPY DOM CLINICAL GUIDELINES AND RECOMMENDED CHANGES BACKGROUND In September 2012, the Division of Medicaid (DOM) implemented criteria through electronic prior authorization (PA)
More informationUsing the NC Controlled Substances Reporting System to Identify Providers Manifesting Unusual Prescribing Practices
Using the NC Controlled Substances Reporting System to Identify Providers Manifesting Unusual Prescribing Practices Prevention Research Center Penn State December 2, 2015 Chris Ringwalt, DrPH* Sharon Schiro,
More informationNM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT FOURTH QUARTER OF 2017 (2017Q4)
NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT FOURTH QUARTER OF 217 () Substance Abuse Epidemiology Section Prescription Drug Overdose Prevention Program Injury and Behavioral Epidemiology Bureau
More informationIdaho DUR Board Meeting Minutes
Idaho DUR Board Meeting Minutes Date: Jan. 16, 2014 Time: 9am-1pm Location: Idaho Medicaid, 3232 Elder Street, Boise, Idaho, Conference Room D-West Moderator: Mark Turner, M.D. Committee Member Present:
More informationAddressing Prescription Drug Abuse. Allan Coukell Senior Director, Drugs and Medical Devices The Pew Charitable Trust
Addressing Prescription Drug Abuse Allan Coukell Senior Director, Drugs and Medical Devices The Pew Charitable Trust Outline 1. Prescription Drug Monitoring Programs 2. Federal policy landscape including
More informationMichigan Automated Prescription System
MAPS Michigan Automated Prescription System Accuracy of Data Edits applied. Most at 95% Two full time technicians. Two part time students. Full time analyst One shared tech and PT programmer. Data uploads
More informationPHYSICAL MEDICINE AND REHABILITATION CSHCN SERVICES PROGRAM PROVIDER MANUAL
PHYSICAL MEDICINE AND REHABILITATION CSHCN SERVICES PROGRAM PROVIDER MANUAL NOVEMBER 2017 CSHCN PROVIDER PROCEDURES MANUAL NOVEMBER 2017 PHYSICAL MEDICINE AND REHABILITATION Table of Contents 30.1 Enrollment......................................................................
More informationPRESCRIPTION MONITORING PROGRAM
State of Connecticut Department of Consumer Protection PRESCRIPTION MONITORING PROGRAM CONNECTICUT S OUTREACH AND EDUCATIONAL EFFORTS Prescription Monitoring Program Prescribers & Pharmacists: How to Access
More informationPREVENTING PRESCRIPTION DRUG ABUSE AND OVERDOSE JUNE 23, 2016 SHERRY L. GREEN
PREVENTING PRESCRIPTION DRUG ABUSE AND OVERDOSE JUNE 23, 2016 SHERRY L. GREEN STATE LAW AND POLICY TRENDS STATE PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS) Transformation into better health care tools
More informationAddressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention
The Accountable Community for Health of King County Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention May 7, 2018 1 Opiate Treatment & Overdose Prevention Project Goal Immediate:
More informationAlthough PDMPs are separately managed and maintained by each state or jurisdiction, the national network facilitates more uniformity among states.
NASCSA Statement for the Record as presented by Barbara A Carter, President, NASCSA Submitted to: Department of Health and Human Services, Food and Drug Administration, Opioid Policy Steering Committee
More informationState of California Department of Justice. Bureau of Narcotic Enforcement
State of California Department of Justice Bureau of Narcotic Enforcement Prescription Drugs in the U.S. At least half of all Americans take one prescription drug regularly, with one in six taking three
More informationA Step-by-Step Guide for Rubicon Pharmacists Delivering the RubiReview Program (SMAP)
A Step-by-Step Guide for Rubicon Pharmacists Delivering the RubiReview Program (SMAP) May 2014 RubiReview Program Overview... 3 Overview... 3 Adherence Packaging (RubiPaks)... 4 Eligibility... 4 Financial
More informationPresentation Objectives
Oregon s PDMP 101 Lisa Millet, MSH, Section Manager Injury and Violence Prevention Section Center for Prevention and Health Promotion Oregon Health Authority Eugene Oregon PDO Summit April 20, 2016 1 Presentation
More informationMARYLAND BOARD OF PHARMACY
MARYLAND BOARD OF PHARMACY CONTRACEPTION REGULATIONSAnd Other Legislative Initiatives THE ROAD FROM CONCEPTUALIZATION TO IMPLEMENTATION Deena Speights-Napata Executive Director Maryland Board of Pharmacy
More informationArkansas Department of Health
Arkansas Department of Health 4815 West Markham Street Little Rock, Arkansas 72205-3867 Telephone (501) 661-2000 Governor Mike Beebe Nathaniel Smith, MD, MPH, Interim Director and State Health Officer
More informationQuestions and answers about HCA s opioid clinical policy for Apple Health (Medicaid)
Questions and answers about HCA s opioid clinical policy for Apple Health (Medicaid) This Q&A covers questions the Health Care Authority (HCA) received during webinars about the opioid clinical policy
More informationNEW PROVIDER ENROLLMENT FOR ADULT SITE
New Jersey Department of Health Vaccines for Children (NJVFC) Program P.O. Box 369 Trenton, NJ 08625-0369 Phone: (609) 826-4862 Fax: (609) 826-4868 INSTRUCTIONS: Email completed New Provider Enrollment
More informationIdaho DUR Board Meeting Minutes
Idaho DUR Board Meeting Minutes Date: July 20, 2017 Time: 9am-12:30pm Location: Holiday Inn Boise Airport 2970 West Elder Street, Boise, Idaho, 83705 Moderator: David Agler, M.D. Committee Member Present:
More informationD. Todd Bess, PharmD 1
s Program as a Tool to Improve Patient Care and Fight the Drug Epidemic D. Todd Bess, Pharm.D. Director April 12, 2018 Disclosure Information I have no financial relationships to disclose. I will not discuss
More informationOPIOID USE DISORDER CENTERS OF EXCELLENCE APPLICATION GENERAL INFORMATION
OPIOID USE DISORDER CENTERS OF EXCELLENCE APPLICATION GENERAL INFORMATION The Department of Human Services (DHS) is implementing 50 opioid use disorder (OUD) Health Homes or Centers of Excellence (COE)
More informationWEAMA November 2017 Legislative Update
Legislative Overview Prepared by Leslie Emerick, Lobbyist November 8, 2017 The election was held on November 7th and it is now determined that the Senate will be controlled by the Democrats in 2018 because
More informationPrescription Drugs: Issues in Treatment, Supervision and Case Management
Prescription Drugs: Issues in Treatment, Supervision and Case Management National Association of Drug Court Professionals Washington, DC July 16, 2013 Agenda Overview of prescription drug diversion and
More informationControlled Substance Prescribing: A Physician s Guide. Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System
Controlled Substance Prescribing: A Physician s Guide Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System Objectives Review schedules of controlled substances and their propensity for
More informationNM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2017 (2017Q3)
NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 217 () Substance Abuse Epidemiology Section Prescription Drug Overdose Prevention Program Injury and Behavioral Epidemiology Bureau
More informationSection I. Short-acting opioid Prior Authorization Criteria
Request for Prior Authorization for Opioid analgesics Website Form www.highmarkhealthoptions.com Submit request via: Fax - 1-855-476-4158 Requests for opioid analgesics may be subject to prior authorization
More informationPediatric Behavioral Health Medication Initiative Prior Authorization (PA) Request Form
Pediatric Behavioral Health Medication Initiative Prior Authorization (PA) Request Form Please fax form to 617.673.0988 or mail to Tufts Health Plan, 705 Mount Auburn Street, Watertown, MA 02472, Attn:
More informationAn Alternative Payment Model Concept for Office-based Treatment of Opioid Use Disorder
An Alternative Payment Model Concept for Office-based Treatment of Opioid Use Disorder CONTENTS I. Need for an Alternative Payment Model for Opioid Use Disorder and Addiction... 2 A. Improving Services
More informationTennessee. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Tennessee Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationPart D PDE Data and the Opioid Epidemic
Part D PDE Data and the Opioid Epidemic State Data Resource Center Acumen, LLC August 30, 2017 3:30-4:30pm ET Outline Background Information on Opioid Use Helpful Part D Elements for Analysis How to Perform
More informationClinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)
Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT) What has changed? Effective January 16, 2018, Coordinated Care will change the requirement for form HCA 13-333 Medication
More information2125 Rayburn House Office Building 2125 Rayburn House Office Building Washington, DC Washington, DC 20515
The Honorable Greg Walden Chairman Ranking Member 2125 Rayburn House Office Building 2125 Rayburn House Office Building Washington, DC 20515 Washington, DC 20515 Chairman Ranking Member Subcommittee on
More informationliterature that drug combinations containing butalbital should not be used in treatment of chronic pain and are not appropriate for long term routine
ACTION: Original BIA p(111397) pa(192459) d: (446870) DATE: 09/16/2013 2:14 PM print date: 04/02/2019 9:58 PM 1. Limit reimbursement for sedative hypnotic agents to the following medications: zolpidem
More informationHarold Rogers Prescription Drug Monitoring Program National Meeting. August 17, 2016
Harold Rogers Prescription Drug Monitoring Program National Meeting August 17, 2016 Assessment of Opioid-Related Deaths in Massachusetts 2 Trends in Opioid-Related Mortality: Massachusetts 350% increase
More informationShawn A. Ryan, MD, MBA Assistant Professor, Dept. of Emergency Medicine, University of Cincinnati Chair of Quality & Patient Safety, Jewish
Shawn A. Ryan, MD, MBA Assistant Professor, Dept. of Emergency Medicine, University of Cincinnati Chair of Quality & Patient Safety, Jewish Hospital-Mercy Health Partners Addiction Specialist, BrightView
More informationEvaluation of the N.C. Prescription
Evaluation of the N.C. Prescription Drug Monitoring Program 2013 National Meeting of the Safe States Alliance and SAVIR MarianaGarrettson Garrettson, MPH Chris Ringwalt, DrPH UNC Injury Prevention Research
More informationDrug Overdoses A Public Health Problem. Marianne Cloeren, MD, MPH, FACOEM, FACP 10/2/2013. Objectives
Drug Overdoses A Public Health Problem Marianne Cloeren, MD, MPH, FACOEM, FACP 10/2/2013 Objectives O Provide an overview of the trends in opioid prescriptions and impact O Consider implications for the
More informationGUIDELINES: PEER REVIEW TRAINING BOD G [Amended BOD ; BOD ; BOD ; Initial BOD ] [Guideline]
GUIDELINES: PEER REVIEW TRAINING BOD G03-05-15-40 [Amended BOD 03-04-17-41; BOD 03-01-14-50; BOD 03-99-15-48; Initial BOD 06-97-03-06] [Guideline] I. Purpose Guidelines: Peer Review Training provide direction
More informationCalifornia. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile California Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationProviderNews FEBRUARY
ProviderNews FEBRUARY 2017 Reminder: decimal billing required on time-based therapy codes for BadgerCare Plus members In accordance with Forward Health guidelines, Security Health Plan requires decimal
More informationReversing the opioid epidemic in Washington State, and a path forward on treating pain
A collaboration of state agencies, working together to improve health care quality for Washington State citizens Reversing the opioid epidemic in Washington State, and a path forward on treating pain CSG
More information11/11/2015. MVAs Suicide Firearms Homicide. Where Can I Find A Copy of the PDMP Law? Why Was the Law Established? Why Was the Law Established?
Where Can I Find A Copy of the PDMP Law? Alabama Uniform Controlled Substances Act Code of Alabama 1975 20-2- (Article 10) -210 through 220 and Rules 420-7-2-.11 through.13 1 Why Was the Law Established?
More information